Regulation of osteoblastogenesis and bone mass by Wnt10b
- PMID: 15728361
- PMCID: PMC552924
- DOI: 10.1073/pnas.0408742102
Regulation of osteoblastogenesis and bone mass by Wnt10b
Abstract
Wnts comprise a family of secreted signaling proteins that regulate diverse developmental processes. Activation of Wnt signaling by Wnt10b inhibits differentiation of preadipocytes and blocks adipose tissue development; however, the effect of Wnt10b on other mesenchymal lineages has not been defined. To explore the physiological role of Wnt signaling in bone development, we analyzed FABP4-Wnt10b mice, which express the Wnt10b transgene in marrow. Femurs from FABP4-Wnt10b mice have almost four times as much bone in the distal metaphyses and are mechanically stronger. These mice maintain elevated bone mass at least through 23 months of age. In addition, FABP4-Wnt10b mice are protected from the bone loss characteristic of estrogen deficiency. We used pharmacological and genetic approaches to demonstrate that canonical Wnt signaling stimulates osteoblastogenesis and inhibits adipogenesis of bipotential mesenchymal precursors. Wnt10b shifts cell fate toward the osteoblast lineage by induction of the osteoblastogenic transcription factors Runx2, Dlx5, and osterix and suppression of the adipogenic transcription factors C/EBPalpha and PPARgamma. One mechanism whereby Wnt10b promotes osteoblastogenesis is suppression of PPARgamma expression. Finally, Wnt10b-/- mice have decreased trabecular bone and serum osteocalcin, confirming that Wnt10b is an endogenous regulator of bone formation.
Figures
) mice at 6 months of age were analyzed for bone volume fraction (B; BV/TV, %), bone mineral density (C; BMD), trabecular number (D; Tr. N.), trabecular thickness (E; Tb. Th.), trabecular spacing (F; Tb. Sp.), ultimate load (G), stiffness (H), and yield load (I). Statistical significance for each measurement was evaluated with Student's t test: P < 0.05 (*), < 0.01 (#), < 0.001 (†), with n = 6 males for each genotype.
) mice. Properties analyzed include bone volume fraction (B;BV/TV, %), bone mineral density (C; BMD), trabecular number (D; Tr. N.), trabecular thickness (E; Tb. Th.), and trabecular spacing (F; Tb. Sp.). Serum levels of osteocalcin (G) and TRAP5b activity (H) in wild-type (▪) and Wnt10b null (
) mice. Statistical significance for each measurement was evaluated with Student's t test: P < 0.05 (*), < 0.01 (#), and <0.001 (†), with n = 6 mice for each genotype.References
-
- Nuttall, M. E. & Gimble, J. M. (2004) Curr. Opin. Pharmacol. 4, 290-294. - PubMed
-
- Ross, S. E., Hemati, N., Longo, K. A., Bennett, C. N., Lucas, P. C., Erickson, R. L. & MacDougald, O. A. (2000) Science 289, 950-953. - PubMed
-
- Bennett, C. N., Ross, S. E., Longo, K. A., Bajnok, L., Hemati, N., Johnson, K. W., Harrison, S. D. & MacDougald, O. A. (2002) J. Biol. Chem. 277, 30998-31004. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AR049682/AR/NIAMS NIH HHS/United States
- DK51563/DK/NIDDK NIH HHS/United States
- P60 DK20572/DK/NIDDK NIH HHS/United States
- AR49682/AR/NIAMS NIH HHS/United States
- P30 AR046024/AR/NIAMS NIH HHS/United States
- N02 DK062876/DK/NIDDK NIH HHS/United States
- RR00161/RR/NCRR NIH HHS/United States
- T32 DE007057/DE/NIDCR NIH HHS/United States
- P60 DK020572/DK/NIDDK NIH HHS/United States
- P30AR046024/AR/NIAMS NIH HHS/United States
- R01 DK051563/DK/NIDDK NIH HHS/United States
- K01 RR000161/RR/NCRR NIH HHS/United States
- DE07057/DE/NIDCR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
